Nordzucker_GB 03-04_E_.pd 1 - Nordzucker AG
Nordzucker_GB 03-04_E_.pd 1 - Nordzucker AG
Nordzucker_GB 03-04_E_.pd 1 - Nordzucker AG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Management Report<br />
Shareholdings Business Development<br />
in t milion<br />
Hübner-Medopharm Syral* Amino**<br />
2002 20<strong>03</strong><br />
2001/02 2002/<strong>03</strong><br />
2002 20<strong>03</strong><br />
Sales<br />
30<br />
31<br />
77<br />
168<br />
46<br />
44<br />
EBIT<br />
1<br />
2<br />
-6<br />
3<br />
3<br />
2<br />
Net income (consolidated)<br />
1<br />
1<br />
-8<br />
2<br />
2<br />
2<br />
Investment in tangible assets<br />
0<br />
1<br />
9<br />
142***<br />
3<br />
2<br />
Staff (average of financial year)<br />
229<br />
210<br />
85<br />
272<br />
346<br />
344<br />
Equity capital<br />
-4<br />
-3<br />
45<br />
44<br />
13<br />
18<br />
<strong>Nordzucker</strong> share (in percent)<br />
98%<br />
98%<br />
36%<br />
50%<br />
50%<br />
50%<br />
* Financial year ended on 30 Sept. each year<br />
2002/<strong>03</strong> figures include Staral<br />
** Sub-group Amino (Amino GmbH, esparma<br />
GmbH, S.A. Bioproducts at equity)<br />
*** Including additions from merger<br />
30<br />
The non-sugar shareholdings are<br />
coordinated within the Business<br />
Development division. The only exception<br />
is the Hübner-Medopharm group,<br />
which because of the 98-percent stake is<br />
fully consolidated. The 50-percent share<br />
holding Syral S.A. and the Amino group<br />
are accounted for in the group with their<br />
equity ratio. SweetGredients is accounted<br />
for on a pro rata basis (proportional consolidation).<br />
Hübner-Medopharm<br />
The main business of the group, in which<br />
<strong>Nordzucker</strong> holds 98 percent, is the production<br />
and marketing of natural food<br />
supplements, medical and cosmetic<br />
products. The main outlets for these<br />
products in Germany are health shops<br />
and dispensing chemists. Exports go to<br />
more than 30 countries.<br />
Satisfactory Sales and Exports<br />
The highly satisfactory development of<br />
the group continued in 20<strong>03</strong>. Although<br />
consumer reluctance also affected the<br />
health shop sector in Germany with<br />
some delay, overall sales increased by<br />
some five percent.<br />
For the dispensing chemists sector, the<br />
seven-percent drop in sales reflects the<br />
strategy of reserving tight field service<br />
resources for customers with profitable<br />
minimum sales. Innovative products<br />
specifically developed for this sector<br />
will bring about an adjustment in 20<strong>04</strong>.<br />
Exports rose by six percent and have<br />
thus continued the favourable trend of<br />
previous years. The increase was not least<br />
due to new customers attracted in non-<br />
European markets.<br />
Modernisation Programme Completed<br />
Commissioning of the new filling and<br />
packaging plant for the core and USP<br />
product ‘Silicea’ in the spring of the year<br />
20<strong>04</strong> completed the modernisation programme<br />
launched when Hübner was<br />
taken over.<br />
SweetGredients<br />
In line with the <strong>Nordzucker</strong> policy of<br />
developing its core activities in a changing<br />
market, <strong>Nordzucker</strong> founded the<br />
company SweetGredients in 20<strong>03</strong>. On